Evidence map›Paper›PMID 41833398›Full record

ReviewEndocrine journal2026

[

Hayao Yoshida, Takaaki Murakami, Kentaro Sakaki, Kanae Kawai Miyake, Yoichi Shimizu, Daisuke Otani, Mari Matsushiro, Koji Itagaki, Kazuyuki Nagai, Tsuyoshi Ohno and 8 more

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hayao YoshidaDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0009-0005-0155-9177
Takaaki MurakamiDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-3844-1138
Kentaro SakakiDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kanae Kawai MiyakeDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoichi ShimizuDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Daisuke OtaniDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Mari MatsushiroDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koji ItagakiDivision of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan.
Kazuyuki NagaiDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tsuyoshi OhnoDepartment of Radiology, Kyoto City Hospital, Kyoto, Japan.
Hiroaki ItoDepartment of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shinya OtsukiMedical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.
Hidefumi InabaDepartment of Physiology, Wakayama Medical University School of Medicine, Wakayama, Japan.
Shizuka KanekoDepartment of Diabetology and Endocrinology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Hiroyuki FujimotoRadioisotope Research Center, Agency for Health, Safety and Environment, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0009-0009-7084-1423
Daisuke YabeDepartment of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-5334-7687
Yuji NakamotoDepartment of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nobuya InagakiMedical Research Institute Kitano Hospital, PIIF Tazuke-Kofukai, Osaka, Japan.ORCID http://orcid.org/0000-0001-8261-2593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulinomas are rare functional pancreatic neuroendocrine tumors that cause hypoglycemia from inappropriate insulin secretion. Surgical resection is curative but hinges on accurate preoperative localization. Conventional imaging with computed tomography and magnetic resonance imaging may miss small lesions, and invasive tests such as endoscopic ultrasound tissue acquisition and the selective arterial calcium stimulation test, while informative, are operator-dependent and not invariably conclusive. Glucagon-like peptide-1 receptor-targeted positron emission tomography has emerged as a sensitive, noninvasive localization tool. A 53-year-old man presented with endogenous hyperinsulinemic hypoglycemia, including a witnessed nocturnal seizure (glucose 27 mg/dL; immunoreactive insulin 40.5 μU/mL). Cross-sectional imaging showed a 10-12 mm hypervascular tumor in the pancreatic head. Glucagon-like peptide-1 receptor imaging with [

Indexed as

InsulinomaPancreatic NeoplasmsExenatideHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographyExenatideGlucagon-like peptide-1 receptorInsulinomaNeuroendocrine tumorPositron emission tomography/magnetic resonance imagingβ-cell imaging

Identifiers

PMID41833398
PMCPMC13271857

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.